Author:
Mohnike Wolfgang,Hör Gustav,Lampe Matthias
Publisher
Springer Berlin Heidelberg
Reference203 articles.
1. Adejolu M, Huo L, Rohren E, Santiago L, Yang WT (2012) False-positive lesions mimicking breast cancer on FDG PET and PET/CT. AJR Am J Roentgenol 198(3): W304–314
2. Adler LP, Faulhaber PF, Schnur KC et al. (1997) Axillary lymphnode metastases: screening with (F-18)2-deoxy-2fluoro-D-glucose (FDG) PET. Radiology 203: 323–327
3. Aukema TS, Rutgers EJT, Vogel WV et al. (2009) Can FDG PET/CT replace conventional imaging in patients with locoregional breast cancer recurrrence? P094: S329
4. Avril N, Dose J, Janicke F, Ziegler S et al. (1996) Assessment of axillary lymphnode involvement in breast cancer patients with positron emission tomography using radiolabeled 2-(fluorine-18)-fluoro-2-deoxyglucose. J Natl Cancer Inst 88: 1204–1209
5. Avril N, Menzel M, Dose J et al. (2001) Glucose metabolism of breast cancer assessed by 18F-FDG PET: Histologic and immunohistochemical tissue analysis. J Nucl Med 42: 9–16